A placebo controlled trial on add-on modafinil on the anti-psychotic treatment emergent hyperglycemia and hyperlipidemia

A placebo controlled trial on add-on modafinil on the anti-psychotic treatment emergent hyperglycemia and hyperlipidemia

Modafinil is non stimulant drug which is marketed for mainly Narcolepsy and daytime drowsiness. The clinical experience and Summary of Product Characteristics (SPC) of the drug also mentions Anorexia as one of the side effects. Anorexia can have a direct impact on the carbohydrate and fat intake, wh...

Full description

Bibliographic Details
Main Authors: Pathapati Lakshmi Prasuna, Kommu John Vijay Sagar, Thatikonda Padma Sudhakar, Gundugurthi Prasada Rao
Format: Article
Language:English
Published: SAGE Publishing 2014-01-01
Series:Indian Journal of Psychological Medicine
Subjects:
Atypical anti-psychotic
clozapine
dyslipidemia
glycemic dysregulation
metabolic syndrome
modafinil
Online Access:http://www.ijpm.info/article.asp?issn=0253-7176;year=2014;volume=36;issue=2;spage=158;epage=163;aulast=Prasuna

Internet

http://www.ijpm.info/article.asp?issn=0253-7176;year=2014;volume=36;issue=2;spage=158;epage=163;aulast=Prasuna

Similar Items